Lazard Asset Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-24
Closed 2311
2024
Q4
$0 Sell
24
-54,551
-100% -$1.39M ﹤0.01% 2290
2024
Q3
$1.34M Buy
54,575
+7,659
+16% +$198K ﹤0.01% 990
2024
Q2
$1.1M Sell
46,916
-8,177
-15% -$201K ﹤0.01% 956
2024
Q1
$1.82M Sell
55,093
-3,413
-6% -$106K ﹤0.01% 840
2023
Q4
$1.59M Sell
58,506
-2,284
-4% -$56.7K ﹤0.01% 889
2023
Q3
$1.46M Sell
60,790
-1,700
-3% -$45.6K ﹤0.01% 911
2023
Q2
$2M Sell
62,490
-15
-0% -$487 ﹤0.01% 889
2023
Q1
$1.91M Buy
62,505
+816
+1% +$32.2K ﹤0.01% 917
2022
Q4
$2.41M Sell
61,689
-52,163
-46% -$2.34M ﹤0.01% 880
2022
Q3
$5.42M Buy
113,852
+5,820
+5% +$332K 0.01% 690
2022
Q2
$4.18M Buy
108,032
+37,182
+52% +$1.48M 0.01% 767
2022
Q1
$4.06M Buy
70,850
+17,722
+33% +$1.16M ﹤0.01% 789
2021
Q4
$4.23M Buy
53,128
+27,322
+106% +$2.34M ﹤0.01% 803
2021
Q3
$2.25M Buy
25,806
+1,215
+5% +$122K ﹤0.01% 896
2021
Q2
$3.17M Buy
24,591
+24,210
+6,354% +$1.93M ﹤0.01% 792
2021
Q1
$30K Buy
+381
New +$36.2K ﹤0.01% 1642

Other funds holding BEAM